Score
3
1987
pubmed
[The immunomodulator thymalin in the experimental chemotherapy of tumors].
Amosova. E N EN; Iaremenko. K V KV; Cherdyntseva. N V NV; Nikolin. V P VP; Ogreba. V I VI
Key Findings
- Thymalin boosted the anti‑cancer effect of standard chemotherapy drugs in mice
- Tumor growth and spread were reduced when thymalin was used
- Mice lived longer and showed less chemotherapy‑induced immune suppression
Practical Outcomes
- For biohackers, thymalin looks like a potential immune‑support add‑on during cancer treatment, but the evidence is only in animals and no human dosing or safety data exist yet. It isn’t ready for a DIY protocol for longevity or performance, though it may warrant monitoring as research progresses.
Summary
In mouse studies, adding the peptide thymalin to chemotherapy helped slow tumor growth, reduced spread, lengthened the animals' lives, and lessened the immune system suppression usually caused by chemo drugs.
Abstract
Experiments on inbred and noninbred mice showed thymalin to potentiate the therapeutic effect of cytostatic drugs. Thymalin treatment was followed by inhibition of tumor growth and dissemination, increase in the animal's life span and amelioration of antitumor drug-induced immunodepression.
Study Information
Provider
pubmed
Year
1987